Episodes
-
Tapinarof’s Place in Inflammatory Disease Treatment
Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the second installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, explain how tapinarof fits in the armamentarium for treating inflammatory...
-
Skin Barrier Maintenance in Atopic Dermatitis and Psoriasis
Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the third installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, describe the importance of skin barrier maintenance in treating inflammatory...
-
Various Benefits of Aryl Hydrocarbon Receptor Agonists
Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the fourth installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, discuss how topical therapies can be used to control inflammation and how to…
more -
Managing Patient Expectations with Topical Therapies
Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the fifth installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, talk about the challenges involved with setting treatment goals with inflammatory...
-
Potential Impact of Aryl Hydrocarbon Activation on Pigment
Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the sixth installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, speculate about normalization of pigment as a potential benefit of aryl…
more -
Mechanism of Action for Aryl Hydrocarbon Receptor Agonists
Host: Neal Bhatia, MD, FAAD Guest: Joshua Grosshandler, MD, FAAD In the first installment of this six-part series, Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Joshua Grosshandler, MD, FAAD, discuss the aryl hydrocarbon receptor (AhR) pathway and how AhR agonists work.
-
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Faculty: Carolyn Lam, MD, PhD Faculty: Stephen J. Greene, MD Using a real-world patient case, Dr. Stephen Greene and Dr. Carolyn Lam explore strategies to optimize care for patients with heart failure with reduced ejection fraction (HFrEF) who remain at elevated risk despite guideline-directed...
-
CKD-aP Uncovered Prevalence & Pathophysiology
Faculty: Steven Fishbane, MD Faculty: Nancy Helou, PhD Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the...
-
When Itching Hurts: Quality of Life Disruption in CKD-aP
Faculty: Nancy Helou, PhD Faculty: Steven Fishbane, MD Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the...
-
Gabapentinoids: Safety Considerations and Downstream Outcomes
Faculty: Federico Alberici, MD, PhD Faculty: Anastasia Liossatou, PhD, RN Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and...
-
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Faculty: Federico Alberici, MD, PhD Faculty: Anastasia Liossatou, PhD, RN Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and...
-
Spotlight on Assessment: Tools That Capture CKD-aP
Faculty: Federico Alberici, MD, PhD Faculty: Anastasia Liossatou, PhD, RN Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and...
-
Reading Between the Lines: What PROMs Reveal About Itch
Faculty: Federico Alberici, MD, PhD Faculty: Anastasia Liossatou, PhD, RN Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and...
-
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
Faculty: Federico Alberici, MD, PhD Faculty: Anastasia Liossatou, PhD, RN Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and...
-
What You Don’t See: A Patient’s View of Living with CKD-aP
Faculty: Steven Fishbane, MD Faculty: Nancy Helou, PhD Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the...
-
Winning the CKD-aP Battle: A United Physician-Nurse Front
Faculty: Steven Fishbane, MD Faculty: Nancy Helou, PhD Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the...
-
Conference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
Faculty: Ravi Savarirayan, MBBS, MD Faculty: Julie Hoover-Fong, MD, PhD, FACMGG In this expert discussion, Drs. Ravi Savarirayan and Julie Hoover-Fong examine how findings from the PROPEL 3 trial of oral infigratinib fit within the evolving treatment landscape for achondroplasia in children. They...
-
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
Faculty: Amer Zeidan, MBBS, MHS Faculty: Ghayas Issa, MD, MS This chapterized expert interview examines six common clinical decision points encountered when incorporating menin inhibitors into the management of relapsed/refractory NPM1-mutated acute myeloid leukemia (AML). Faculty discuss...
-
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
Faculty: Kathleen N. Moore, MD Faculty: Ritu Salani, MD This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibitors,...
-
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
Faculty: Kathleen N. Moore, MD Faculty: Ritu Salani, MD This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibitors,...
-
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
Faculty: Kathleen N. Moore, MD Faculty: Ritu Salani, MD This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibitors,...
-
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
Faculty: Kathleen N. Moore, MD Faculty: Ritu Salani, MD This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibitors,...
-
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
Faculty: Kathleen N. Moore, MD Faculty: Ritu Salani, MD This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibitors,...
-
Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
Host: Alex F. Herrera, MD This online activity is designed to provide the healthcare team with the latest developments and critical insights into Hodgkin lymphoma treatment. This education will support the healthcare professional in his/her practice setting with the essential tools to critically...
-
Rewriting the Calcium Code in ADH1
Faculty: Michael A. Levine, MD, ML, MACE Faculty: Aliya Khan, MD, FRCPC, FACP, FACE, FASBMR In this expert discussion, Drs. Michael Levine and Aliya Khan review emerging evidence in autosomal dominant hypocalcemia type 1 (ADH1), including findings from the CALIBRATE trial presented at ENDO 2026....
-
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
Faculty: Neal Ready, MD, PhD This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens such as fucosyl-GM1, DLL3, and B7-H3,...
-
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
Faculty: Neal Ready, MD, PhD This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens such as fucosyl-GM1, DLL3, and B7-H3,...
-
Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC
Faculty: Ticiana Leal, MD This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens such as fucosyl-GM1, DLL3, and B7-H3…
more -
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage
Faculty: Ticiana Leal, MD This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens such as fucosyl-GM1, DLL3, and B7-H3…
more -
Translating Research Into Practice in Breast Cancer: Emerging Data and the Expanding Role of ADCs
Faculty: Sara A. Hurvitz, MD, FACP Faculty: Tiffany Traina, MD, FASCO The role of antibody-drug conjugate (ADC) therapy has been well established in metastatic breast cancer. Recent phase 3 data have provided evidence for expanded indications for early breast cancer and triple-negative breast...
-
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
Faculty: Maria Fleseriu, MD, FACE Faculty: Beverly MK Biller, MD, FACP Faculty: Mark Gurnell, MD This program is a replay of the live symposium held at ENDO 2026. This program reviews challenges in diagnosis and management of acromegaly, with an emphasis on earlier recognition and informed…
more -
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for...
-
The Evidence Base: Key Trials and Emerging Data
Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for...
-
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for...
-
From Data to Decision: Patient Selection and Real-World Application
Faculty: Christophe Le Tourneau, MD, PhD Faculty: Marc Oliva, MD, PhD This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for...
-
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Faculty: Aditya Bardia, MD, MPH, FASCO Faculty: Erica L. Mayer, MD, MPH Oral selective estrogen receptor degraders (SERDs) are rapidly reshaping the treatment landscape in breast cancer, offering targeted treatment approaches that have demonstrated improvements in progression-free survival and...
-
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy,...
-
The Power of Timing: Therapies That Change Outcomes
Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy,...
-
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy,...
-
Precision in Practice—Bringing Targeted Therapy to mHSPC
Faculty: Scott T. Tagawa, MD, MS Faculty: Mary-Ellen Taplin, MD This activity explores current approaches to treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC), including androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), chemotherapy,...
-
Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
Faculty: Linda Stein Gold, MD Faculty: Lakshi Aldredge, MSN, ANP-BC Faculty: Najat M. Watch, PA Psoriasis management often begins with topical therapies, phototherapy, or established biologics before escalation. This Broadcast Replay examines earlier biologic use and the role of oral IL-23…
more -
Diagnosing Rett Syndrome: A Lifespan Approach to Clinical Recognition
Faculty: Payal Kenia Gu, MD Faculty: Edward Dabrowski, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of...
-
Clinical Pearls in Recognizing Rett Syndrome: Early Signs and Diagnosis
Faculty: Payal Kenia Gu, MD Faculty: Edward Dabrowski, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of...
-
Managing Rett Syndrome: Building a Multidisciplinary Care Approach
Faculty: Jennifer Martelle Tu, MD, PhD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis…
more -
Clinical Pearls in Rett Syndrome Management: Practical Approaches to Multidisciplinary Care
Faculty: Jennifer Martelle Tu, MD, PhD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis…
more -
Managing Rett Syndrome: Building a Multidisciplinary Care Approach
Faculty: Payal Kenia Gu, MD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role...
-
Clinical Pearls in Adult Rett Syndrome Care: Supporting Long-Term Needs
Faculty: Payal Kenia Gu, MD Faculty: David Lieberman MD, PhD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role...
-
Transitioning to Adult Care in Rett Syndrome: Navigating Challenges
Faculty: Jennifer Martelle Tu, MD, PhD Faculty: Payal Kenia Gu, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and…
more -
Clinical Pearls in Transition: Supporting Patients and Families Into Adulthood
Faculty: Jennifer Martelle Tu, MD, PhD Faculty: Payal Kenia Gu, MD This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and…
more -
Current Unmet Needs in First-Line Treatment of Metastatic TNBC
Faculty: Javier Cortes, MD, PhD This online educational activity examines the evolving role of TROP2-directed antibody-drug conjugates (ADCs) in the frontline management of metastatic triple-negative breast cancer (TNBC). Through expert-led reviews and case-based discussions, the activity…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
Loading similar podcasts...
Frequently Asked Questions
How many episodes does CME have?
CME currently has 418 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is CME about?
CME is a podcast covering topics in science.
How often does CME release new episodes?
CME publishes regularly with 418 episodes available. Check the episode list for the typical release schedule.
Where can I listen to CME?
You can listen to CME on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts CME?
CME is created and hosted by ReachMD.
URL copied to clipboard!